How many insider declarations has Adage Capital Management, L.P. filed?

Adage Capital Management, L.P. has filed 2 public insider declarations with SEC (Form 4).

What is Adage Capital Management, L.P.'s role?

Adage Capital Management, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does Adage Capital Management, L.P. report trades for?

Adage Capital Management, L.P. reports trades for 2 companies, including Solid Biosciences Inc..

What is Adage Capital Management, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 1.8M€ and disposals 969k€.

← Executives ★ Sign in to follow

AC

Adage Capital Management, L.P.

·SEC (Form 4)

Solid Biosciences Inc.Praxis Precision Medicines, Inc.

0

Total declarations

0

Companies

€2m

▲ Purchases (1 ops.)

€969,291

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

1

T+90 hit rate

0%

T+90 mean return

-55.0%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Explore the detailed record of transactions filed by Adage Capital Management, L.P.. Officer active across 2 companies, notably Solid Biosciences Inc.. Aggregated, 2 disclosures have been published. Split: 1 buy · 1 sell. Total volume traded: €2.8m. Activity tracked since 18 February 2025. The latest transaction was filed on 16 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Adage Capital Management, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Solid Biosciences Inc. (US)Praxis Precision Medicines, Inc. (US)

Declarations2 total

▼

Adage Capital Management, L.P.

Executives16 Oct 2025Praxis Precision Medicines, Inc.

$1M10SEC ↗

12,600 shares@ US$90.0025100.0% of flowCommon Stock, $0.0001 par value per share ("Common Stock")SEC:0000902664-25-004455:0

▲

Adage Capital Management, L.P.

Executives18 Feb 2025Solid Biosciences Inc.

$2M32SEC ↗

252,545 shares@ US$7.56100.0% of flowCommon Stock, $0.001 par value per shareSEC:0000902664-25-001114:0

Canonical exit: 19 May 2025 (T+90)

2 of 2 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

AC

Adage Capital Management, L.P.

·SEC (Form 4)

Solid Biosciences Inc.Praxis Precision Medicines, Inc.

0

Total declarations

0

Companies

€2m

▲ Purchases (1 ops.)

€969,291

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

1

T+90 hit rate

0%

T+90 mean return

-55.0%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Explore the detailed record of transactions filed by Adage Capital Management, L.P.. Officer active across 2 companies, notably Solid Biosciences Inc.. Aggregated, 2 disclosures have been published. Split: 1 buy · 1 sell. Total volume traded: €2.8m. Activity tracked since 18 February 2025. The latest transaction was filed on 16 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.